Monoclonal antibody treatmentBMJ 2010; 340 doi: https://doi.org/10.1136/bmj.c1850 (Published 01 April 2010) Cite this as: BMJ 2010;340:c1850
- Oscar M Jolobe, retired geriatrician1
- 1Manchester Medical Society, c/o John Rylands University Library, Manchester M13 9PP
The risk of relapse of Clostridium difficile diarrhoea is 20-25%1 2 3 and can be mitigated by co-prescription of monoclonal antibodies directed against …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial